136 related articles for article (PubMed ID: 6455212)
1. A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery.
Maeda H; Sano Y; Takeshita J; Iwai Z; Kosaka H; Marubayashi T; Matsukado Y
Cancer Chemother Pharmacol; 1981; 5(4):243-9. PubMed ID: 6455212
[TBL] [Abstract][Full Text] [Related]
2. [Part I. Theory and computer simulation for cerebrospinal infusion].
Maeda H; Matsukado Y; Iwai Z; Uemura S; Kuratsu J; Takeshita J; Sano Y
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1040-5. PubMed ID: 6223592
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic one-compartment model using neocarzinostain as a prototype drug and its clinical application to chemotherapy for brain tumor. Part II. A clinical trial with selected protocol].
Matsukado Y; Maeda H; Uemura S; Kuratsu J; Sonoda H
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1933-41. PubMed ID: 6223589
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigations of neocarzinostatin in Japan.
Kimura I
Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
[TBL] [Abstract][Full Text] [Related]
5. Synergistic Anti-glioma Effects in Vitro and in Vivo of Enediyne Antibiotic Neocarzinostatin and Paclitaxel via Enhanced Growth Delay and Apoptosis-Induction.
Tianqin G; Chunlei C; Jingjing W
Biol Pharm Bull; 2016 Oct; 39(10):1623-1630. PubMed ID: 27431785
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of malignant glioma with neocarzinostatin. A combined chemoradiotherapy with intra-arterial neocarzinostatin perfusion and irradiation].
Uemura S; Matsukado Y; Sonoda H; Kuratsu J; Ohtsuka T; Yoshioka S; Yoshida A; Kochi M; Marubayashi T
Neurol Med Chir (Tokyo); 1986 Apr; 26(4):304-10. PubMed ID: 2429207
[No Abstract] [Full Text] [Related]
7. Clinical pharmacology of the anticancer polypeptide neocarzinostatin.
Hall SW; Knight J; Broughton A; Benjamin RS; McKelvey E
Cancer Chemother Pharmacol; 1983; 10(3):200-4. PubMed ID: 6222845
[TBL] [Abstract][Full Text] [Related]
8. [Neocarzinostatin therapy of advanced renal cell carcinoma].
Tari K; Satake I; Kojima S; Tsujii T; Yonese J
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.
Maeda H; Sakamoto S; Ogata J
Antimicrob Agents Chemother; 1977 Jun; 11(6):941-5. PubMed ID: 141906
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of neocarzinostatin in patients with malignant glioma. Quantitative analysis of tissue concentration].
Otsuka T; Matsukado Y; Uemura S; Kuratsu J; Sonoda H; Mihara Y; Goto S
Neurol Med Chir (Tokyo); 1989 Jun; 29(6):471-5. PubMed ID: 2479848
[TBL] [Abstract][Full Text] [Related]
11. Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma.
Otsuji E; Takahashi T; Yamaguchi T; Yamaguchi N; Imanishi J
Gastroenterol Jpn; 1990 Apr; 25(2):244-8. PubMed ID: 2140808
[TBL] [Abstract][Full Text] [Related]
12. Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin.
Shimoyama M; Kimura K
Gan; 1979 Apr; 70(2):165-71. PubMed ID: 157307
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of cytotoxicity of zinostatin under acidic conditions in vitro and in vivo.
Kuroiwa T; Taniguchi S; Aoki K; Hasuda K; Baba T
Cancer Treat Rep; 1987 Mar; 71(3):247-51. PubMed ID: 2949830
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of a rat meningeal gliomatosis model with neocarzinostatin].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y; Egawa T
No To Shinkei; 1987 Jul; 39(7):615-9. PubMed ID: 2960332
[TBL] [Abstract][Full Text] [Related]
15. [Use of arterial infusion of neocarzinostatin with or without combination chemotherapy as a treatment of carcinoma of the prostate].
Yuasa M; Numata A; Tanaka T; Kawanishi Y; Yamamoto A; Imagawa A
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2325-30. PubMed ID: 2425748
[TBL] [Abstract][Full Text] [Related]
16. [Reductive effect on ascites, of neocarzinostatin in patients with ovarian cancer].
Takahashi K; Watanabe M; Kikuchi J; Kishi H; Saito K; Mouri H; Ikeno N; Endo H; Shima I; Morizuka T
Gan To Kagaku Ryoho; 1988 May; 15(5):1777-81. PubMed ID: 2967052
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of meningeal carcinomatosis--neocarzinostatin perfusion therapy in the CSF pathway].
Uemura S; Matsukado Y; Fujioka S; Kuratsu J; Sonoda H; Yano T; Ohtsuka T; Yoshioka S
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1794-800. PubMed ID: 2931051
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of selective continuous internal carotid CDDP infusion in malignant brain tumors.
Seiki Y; Shibata I; Terao H; Kudo M; Noguchi T
Neurol Med Chir (Tokyo); 1991 Nov; 31(11):695-701. PubMed ID: 1723156
[TBL] [Abstract][Full Text] [Related]
19. Zinostatin (neocarzinostatin).
Issell BF; Prestayko AW; Comis RL; Crooke ST
Cancer Treat Rev; 1979 Dec; 6(4):239-49. PubMed ID: 161199
[No Abstract] [Full Text] [Related]
20. Targeted chemotherapy in mice with peritoneally disseminated gastric cancer using monoclonal antibody-drug conjugate.
Okamoto K; Yamaguchi T; Otsuji E; Yamaoka N; Yata Y; Tsuruta H; Kitamura K; Takahashi T
Cancer Lett; 1998 Jan; 122(1-2):231-6. PubMed ID: 9464516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
